264 related articles for article (PubMed ID: 15475053)
1. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall.
Isenburg JC; Simionescu DT; Vyavahare NR
Biomaterials; 2005 Apr; 26(11):1237-45. PubMed ID: 15475053
[TBL] [Abstract][Full Text] [Related]
2. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid.
Isenburg JC; Simionescu DT; Vyavahare NR
Biomaterials; 2004 Jul; 25(16):3293-302. PubMed ID: 14980424
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for stabilization of vascular elastin by polyphenolic tannins.
Isenburg JC; Karamchandani NV; Simionescu DT; Vyavahare NR
Biomaterials; 2006 Jul; 27(19):3645-51. PubMed ID: 16527345
[TBL] [Abstract][Full Text] [Related]
4. Mitigated calcification of glutaraldehyde-fixed bovine pericardium by tannic acid in rats.
Wang D; Jiang H; Li J; Zhou JY; Hu SS
Chin Med J (Engl); 2008 Sep; 121(17):1675-9. PubMed ID: 19024098
[TBL] [Abstract][Full Text] [Related]
5. [Effect of tannic acid treatment on the physico-chemical properties of glutaraldehyde-fixed bovine jugular vein].
De W; Zhou JY; Hu SS; Jiang H; Wang S; Li J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):65-7. PubMed ID: 19317063
[TBL] [Abstract][Full Text] [Related]
6. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.
Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):99-105. PubMed ID: 11805957
[TBL] [Abstract][Full Text] [Related]
7. Role of elastin in pathologic calcification of xenograft heart valves.
Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR
J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435
[TBL] [Abstract][Full Text] [Related]
8. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Biomed Mater Res A; 2003 Sep; 66(4):755-63. PubMed ID: 12926026
[TBL] [Abstract][Full Text] [Related]
10. Amide cross-linking: an alternative to glutaraldehyde fixation.
Girardot JM; Girardot MN
J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
12. Elastin Stabilization Through Polyphenol and Ferric Chloride Combined Treatment for the Enhancement of Bioprosthetic Heart Valve Anticalcification.
Jin W; Guo G; Chen L; Lei Y; Wang Y
Artif Organs; 2018 Nov; 42(11):1062-1069. PubMed ID: 30058211
[TBL] [Abstract][Full Text] [Related]
13. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879
[TBL] [Abstract][Full Text] [Related]
14. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies.
Vyavahare NR; Jones PL; Hirsch D; Schoen FJ; Levy RJ
J Heart Valve Dis; 2000 Jul; 9(4):561-6. PubMed ID: 10947050
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
Chen W; Kim JD; Schoen FJ; Levy RJ
J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
[TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization.
Mercuri JJ; Lovekamp JJ; Simionescu DT; Vyavahare NR
Biomaterials; 2007 Jan; 28(3):496-503. PubMed ID: 17030363
[TBL] [Abstract][Full Text] [Related]
17. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions.
Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW
J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511
[TBL] [Abstract][Full Text] [Related]
18. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
Flomenbaum MA; Schoen FJ
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.
Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ
J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794
[TBL] [Abstract][Full Text] [Related]
20. Prevention of porcine aortic wall calcification by acellularization: necessity for a non-glutaraldehyde-based fixation treatment.
Meuris B; Verbeken E; Flameng W
J Heart Valve Dis; 2005 May; 14(3):358-63; discussion 363-4. PubMed ID: 15974531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
